Study A - MK0767 Monotherapy Study
Status and phase
Terminated
Phase 3
Conditions
Diabetes Mellitus, Type 2
Treatments
Drug: MK0767
Details and patient eligibility
About
The purpose of this study is to test if MK0767 lowers blood glucose after 20 weeks compared to placebo.
This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
Enrollment
99 patients
Sex
All
Ages
21 to 78 years old
Volunteers
No Healthy Volunteers
Inclusion criteria
- Patients with Type 2 Diabetes
- Non-pregnant females and patients who agree not to become pregnant during the study
Exclusion criteria
- Patients with Type 1 Diabetes
- Patients who have been treated with insulin or other antihyperglycemic agents
- Patients with viral hepatitis, active liver or gallbladder disease, history of pancreatitis, heart disease, congestive heart failure, inadequately controlled hypertension, HIV positive, history hematologic disorders or neoplastic disease
Trial design
Primary purpose
Treatment
Allocation
Randomized
Interventional model
Parallel Assignment
Masking
Double Blind
Trial contacts and locations
0
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems